A randomized, double-blind, placebo-controlled phase Ib clinical trial of AK111 injection in patients ... the AK111 dose selection for phase 2/3 trials. The PK profile of AK111 was well described by a ...

Liver fibrosis was induced by subcutaneous injection of a 2:3 solution of CCl 4 and olive oil (2.5ul/g body weight) twice per week (CCl 4 model) for 7 weeks as previously ... with serum-free medium.

Multiple subcutaneous ... an injection in the eye. Over 50 subjects have been treated to date across three clinical trials. The interim results of the chronic subQ MGB dosing Phase 2 study for ...

Multiple subcutaneous doses safe and well-tolerated >69% reduction in anti-VEGF intravitreal (IVT) treatment burden in study eyes >67% reduction in anti-VEGF IVT treatment in fellow eyes of bilateral ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Back in December, Gemini 2.0 Flash Thinking was announced as Google’s first reasoning model and an updated experimental version is now available to test. We’ve also enabled code execution as ...

The SAD study consists of five cohorts (2 mg, 5 mg, 10 mg, 20 mg and 40 mg) with a total of 40 patients with obesity under fasting conditions. ASC30 oral tablet demonstrated dose-proportional ...

Most recently, the Food and Drug Administration (FDA) approved treatment with the subcutaneous injection formulation of Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) for patients with solid tumors ...

The Dec. 27, 2024, Food and Drug Administration (FDA) approval of the subcutaneous injection formulation of Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) for patients with solid tumors opened up ...

SINGAPORE – There will be 1,299 more certificates of entitlement (COEs) available for tender in the February to April period than in the preceding three months, marking an increase of 8.2 per cent.

a year capped by impressive model updates to Google DeepMind Veo 2, Pika 2.0, Luma AI’s Ray2 and OpenAI’s Sora, which made its awaited public release. AI companies are still actively pitching ...